Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP:: Pivotal role of M boxes (GTCATGTGCT) and of microphthalmia

被引:291
作者
Bertolotto, C [1 ]
Buscà, R [1 ]
Abbe, P [1 ]
Bille, K [1 ]
Aberdam, E [1 ]
Ortonne, JP [1 ]
Ballotti, R [1 ]
机构
[1] INSERM U385, Fac Med, F-06107 Nice 02, France
关键词
D O I
10.1128/MCB.18.2.694
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In melanocytes and in melanoma cells, cyclic AMP (cAMP)-elevating agents stimulate melanogenesis and increase the transcription of tyrosinase, the rate-limiting enzyme in melanin synthesis. However, two other enzymes, tyrosinase-related protein I (TRP1) and TRP2, are required for a normal melanization process leading to eumelanin synthesis. In B16 melanoma cells, we demonstrated that stimulation of melanogenesis by cAMP-elevating agents results in an increase in tyrosinase, TRP1, and TRP2 expression, cAMP, through a cAMP-dependent protein kinase pathway, stimulates TRP1 and TRP2 promoter activities in both B16 mouse melanoma cells and normal human melanocytes. Regulation of the TRP1 and TRP2 promoters by cAMP involves a hi box and an E box. Further, a classical cAMP response element-like motif participates in the cAMP responsiveness of the TRP2 promoter, demonstrating that the TRP2 gene is subjected to different regulatory processes, which could account for its different expression patterns during: embryonic development or under specific physiological and pathological conditions. We also found that microphthalmia, a basic helix-loop-helix transcription factor, strongly stimulates the transcriptional activities of the TRP1 and TRP2 promoters, mainly through binding to the M boxes. Additionally, we demonstrated that cAMP increases microphthalmia expression and thereby its binding to TRP1 and TRP2 M boxes. These convergent and compelling results disclose at least a part of the molecular mechanism involved in the regulation of melanogenic gene expression by cAMP and emphasize the pivotal role of microphthalmia in this process.
引用
收藏
页码:694 / 702
页数:9
相关论文
共 42 条
[1]   MITOGENIC AND MELANOGENIC STIMULATION OF NORMAL HUMAN MELANOCYTES BY MELANOTROPIC PEPTIDES [J].
ABDELMALEK, Z ;
SWOPE, VB ;
SUZUKI, I ;
AKCALI, C ;
HARRIGER, MD ;
BOYCE, ST ;
URABE, K ;
HEARING, VJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1789-1793
[2]  
ABDELMALEK ZA, 1987, CANCER RES, V47, P3141
[3]   DOPACHROME OXIDOREDUCTASE - A NEW ENZYME IN THE PIGMENT PATHWAY [J].
BARBER, JI ;
TOWNSEND, D ;
OLDS, DP ;
KING, RA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 83 (02) :145-149
[4]   MELANOCYTE-SPECIFIC EXPRESSION OF THE HUMAN TYROSINASE PROMOTER - ACTIVATION BY THE MICROPHTHALMIA GENE-PRODUCT AND ROLE OF THE INITIATOR [J].
BENTLEY, NJ ;
EISEN, T ;
GODING, CR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :7996-8006
[5]   Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: Implication of the microphthalmia gene product [J].
Bertolotto, C ;
Bille, K ;
Ortonne, JP ;
Ballotti, R .
JOURNAL OF CELL BIOLOGY, 1996, 134 (03) :747-755
[6]  
DAY RN, 1989, J BIOL CHEM, V264, P431
[7]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[8]   MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY AND AP-1 ARE ACTIVATED DURING CAMP-INDUCED MELANOGENESIS IN B-16 MELANOMA-CELLS [J].
ENGLARO, W ;
REZZONICO, R ;
DURANDCLEMENT, M ;
LALLEMAND, D ;
ORTONNE, JP ;
BALLOTTI, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24315-24320
[9]   ROLE OF RNA AND PROTEIN-SYNTHESIS IN MEDIATING THE ACTION OF MSH ON MOUSE MELANOMA-CELLS [J].
FULLER, BB ;
VISKOCHIL, DH .
LIFE SCIENCES, 1979, 24 (26) :2405-2415
[10]   Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene [J].
Fuse, N ;
Yasumoto, K ;
Suzuki, H ;
Takahashi, K ;
Shibahara, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (03) :702-707